Posts With Tag Entera Bio Ltd

Explore Entera Bio Ltd.'s 8-K report dated January 10, 2025, detailing warrant issuance and ordinary shares. Key insights on SEC compliance and NASDAQ listing under ENTX.

Explore Entera Bio Ltd.'s latest 8-K/A report revealing ordinary shares, warrants, and financial updates as of July 31, 2024. Essential for investors tracking ENTX.